We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.71T
| $1.31B | 2.47% |
2,634,181
+195,824
| +8% | +$85M |
|
2
NVIDIA
NVDA
$5.44T
| $1.19B | 2.24% |
7,519,089
+447,934
| +6% | +$56.4M |
|
3
Amazon
AMZN
$2.77T
| $858M | 1.62% |
3,910,639
+334,265
| +9% | +$66.1M |
|
4
Apple
AAPL
$4.55T
| $724M | 1.36% |
3,527,854
+430,744
| +14% | +$87M |
|
|
5
Alphabet (Google) Class A
GOOGL
$4.16T
| $674M | 1.27% |
3,824,413
+1,301,317
| +52% | +$213M |
|
6
AbbVie
ABBV
$455B
| $635M | 1.19% |
3,418,332
+134,942
| +4% | +$25.1M |
|
|
7
Palantir
PLTR
$440B
| $629M | 1.18% |
4,614,522
+1,883,721
| +69% | +$221M |
|
8
Amgen
AMGN
$236B
| $606M | 1.14% |
2,171,824
+134,655
| +7% | +$38.1M |
|
9
Verizon
VZ
$205B
| $596M | 1.12% |
13,776,271
-185,332
| -1% | -$8.03M |
|
|
10
Broadcom
AVGO
$1.74T
| $561M | 1.06% |
2,035,381
+800,475
| +65% | +$174M |
|
11
PNC Financial Services
PNC
$96.5B
| $518M | 0.97% |
2,776,517
+845,148
| +44% | +$143M |
|
12
ExxonMobil
XOM
$643B
| $489M | 0.92% |
4,539,739
+1,133,620
| +33% | +$121M |
|
13
Pfizer
PFE
$159B
| $463M | 0.87% |
19,118,939
+1,526,230
| +9% | +$35.6M |
|
|
14
Philip Morris
PM
$300B
| $461M | 0.87% |
2,529,521
-1,629,078
| -39% | -$280M |
|
15
US Bancorp
USB
$96.8B
| $449M | 0.85% |
9,931,308
+445,694
| +5% | +$18.7M |
|
16
Chevron
CVX
$389B
| $435M | 0.82% |
3,037,714
-100,223
| -3% | -$14.1M |
|
17
Johnson & Johnson
JNJ
$637B
| $423M | 0.8% |
2,766,239
-145,054
| -5% | -$22.3M |
|
18
Costco
COST
$419B
| $416M | 0.78% |
420,334
-12,200
| -3% | -$12.1M |
|
19
Truist Financial
TFC
$61.3B
| $414M | 0.78% |
9,632,481
+120,842
| +1% | +$4.73M |
|
20
Duke Energy
DUK
$94B
| $410M | 0.77% |
3,477,679
+1,075
| +0% | +$127K |
|
21
Ameriprise Financial
AMP
$49.4B
| $399M | 0.75% |
747,083
+136,761
| +22% | +$67.6M |
|
22
American Electric Power
AEP
$66.6B
| $397M | 0.75% |
3,830,930
+138,440
| +4% | +$14.4M |
|
23
Meta Platforms (Facebook)
META
$1.48T
| $376M | 0.71% |
509,309
-57,292
| -10% | -$35.4M |
|
|
24
Zscaler
ZS
$30.5B
| $368M | 0.69% |
1,171,983
+888,888
| +314% | +$222M |
|
25
Spotify
SPOT
$110B
| $365M | 0.69% |
475,716
-78,408
| -14% | -$50.3M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.